President to nominate one and appoint three 02/10/06

President George W. Bush today announced his intention to nominate one individual and appoint three individuals to serve in his Administration:

The President intends to nominate Andrew B. Steinberg, of Maryland, to be Assistant Secretary of Transportation for Aviation and International Affairs. Mr. Steinberg currently serves as Chief Counsel for the Federal Aviation Administration at the Department of Transportation. Prior to this, he served as Vice President, General Counsel and Secretary for Church & Dwight Co., Inc. He was also Executive Vice President for Administration, General Counsel and Corporate Secretary for Travelocity.com, Inc, and Executive Vice President and General Counsel for Sabre. Earlier in his career, Mr. Steinberg served as Associate General Counsel for American Airlines. Mr. Steinberg received his bachelor's degree from Princeton University and his JD from Harvard University Law School.

The President intends to appoint Julianna M. Cellini, of Illinois, to be a Member of the Abraham Lincoln Bicentennial Commission, for the Life of the Commission.

The President intends to appoint Trung Dung, of California, to be a Member of the Board of Directors of the Vietnam Education Foundation, for the remainder of a three-year term expiring April 17, 2007.

The President intends to appoint Richard J. Wall, of California, to be a Member of the Board of Directors of the Vietnam Education Foundation, for the remainder of a three-year term expiring April 17, 2008.

# # # For Immediate Release, Office of the Press Secretary, February 9, 2006, Personnel Announcement

more at President Bush or White House or Nominations and Transportation or Abraham Lincoln Bicentennial Commission and Vietnam Education Foundation or Aviation and International Affairs and Andrew B. Steinberg or Trung Dung

RELATED: Keywords announced his intention to nominate, Friday, February 03, 2006 President to nominate five, appoint four, designate one, Wednesday, January 18, 2006 President to nominate ten appoint four individuals and designate one, Wednesday, December 28, 2005 Presidentto nominate three, appoint seventeen 12/28/05, Wednesday, December 28, 2005 President to nominate three, appoint two, designate one, Thursday, December 15, 2005 President to nominate four, appoint four, Thursday, December 15, 2005 District Judge Nominations Sent to the Senate, Wednesday, November 16, 2005 President to nominate four and appoint one, Wednesday, November 02, 2005 President to nominate two appoint one 11/02/05, Thursday, October 06, 2005 President to nominate three to Administration, Thursday, September 08, 2005 President to nominate two appoint two 09/08/05 , Thursday, August 25, 2005 President to nominate three 08/25/05 , Wednesday, August 24, 2005 President to nominate four appoint one , Thursday, August 18, 2005 President to nominate one appoint three, Wednesday, August 17, 2005 President to nominate four, designate two, Thursday, August 11, 2005 The President to nominate two, designate one 08/11/05,

Nanotech to improve health care delivery

Nanotech to improve health care delivery – at the molecular scale

Nanotechnology's potential for improving drug delivery, tissue regeneration and laboratory miniaturization is being explored by a diverse array of University of Michigan researchers.

A handful of these leading scientists from engineering, public health, dentistry and medicine discussed the promise of nanotechnology for oral health diagnosis and treatment on a special panel at the AAAS Annual Meeting on Feb. 17.

Drug delivery

To help get the most potent anti-cancer drugs off the shelf and into the clinic, U-M researchers are looking at two nanotechnology approaches to precisely deliver drugs and visualize individual cells.

One system is a star-shaped synthetic molecule called a dendrimer, and the other is a tiny plastic bead called a PEBBLE.

A dendrimer is a star-shaped synthetic molecule that can be as small as three or four nanometers in diameter, about the size of a single molecule of hemoglobin in a red blood cell. That means it is also fine enough to slip through the walls of blood vessels and get inside cells.

James R. Baker Jr. is leading the dendrimer projects as director of the Michigan Nanotechnology Institute for Medicine and Biological Sciences, with support from the National Cancer Institute, NASA, and the Bill and Melinda Gates Foundation.

The ends of a dendrimer's many branching arms can be studded with molecules that bind to specific receptors on the surface of cancer cells. Other arms of the molecule can carry chemicals to mark or even kill the target cells. Injected into the bloodstream, dendrimers converge on cancer cells, then actually enter the cells. There, they deliver the drugs that kill cancer cells. In preliminary animal studies, drugs appear to be 50 to 100 times more effective with this sort of direct delivery, Baker said.

A group led by toxicologist Martin Philbert and biophysicist Raoul Kopelman is working with tiny plastic beads called PEBBLES-probes encapsulated by biologically localized embedding.

Sized at 20 to 600 nanometers, PEBBLES can be coated with targeting molecules and used as a very precise contrast agent for imaging and drug delivery. Once they reach their goal, sound or light can trigger them to carry out their mission. In some cases, the killer agent can be something as simple as reactive oxygen, says Philbert, a professor of toxicology and senior associate dean for research in U-M's School of Public Health.

Though the PEBBLEs group has done work to get the tiny balls inside cells, including using a gene gun that blasts them like little bullets and attaching them to liposomes and letting the body's own fats provide the transportation, Philbert notes that penetration isn't always necessary to get the medical benefits. He says the tiny balls latched on to the outside of selected cells can deliver "killer oxygen" on cue to kill off the cell without penetrating it.

Tissue regeneration

Panel co-organizer David Kohn, professor of biologic and materials science in the U-M Dental School and biomedical engineering in the College of Engineering, studies bone structure at the molecular level. In experiments that use tissue engineering to build bone and other mineralized tissue, Kohn said, "we use a process that's like nature's, but certainly not as elegant."

The nanoscale structure of bone is crucial to its ability to balance strength and light weight, Kohn explains. Many anti-osteoporosis drugs on the market today merely add mineral mass, without doing enough to duplicate the mechanical properties of bone. "Mass alone is not enough to impart fracture resistance," Kohn said. Kohn's recent work is exploring ways to control the mineral composition and structure of new bone.

Laboratory miniaturization: Reconfigurable cell adhesion substrates

A team led by Shuichi Takayama, assistant professor of biomedical engineering, has replicated the nano-scale features and stickiness of cell-adhesion molecules in a laboratory device. Studying how the surface of a cell interacts with adhesion proteins is key to understanding signal transduction, growth, differentiation, motility and cell death. But in vitro models are hard to come by.

Takayama's team has developed a substrate that can be split into parallel cracks and then lined with cell adhesion proteins to study cellular responses. The cracks may be tailored from 120 to 3200 nanometers, making them similar in size to the adhesion surfaces found in nature. The cracks may also be adjusted in situ to study changes in cell behavior. ###

AAAS Annual Meeting Advanced Seminar Oral Nanotechnology: Innovative Strategies for Disease Detection, Diagnosis, and Therapy 8:30 a.m. CST, Friday, Feb. 17.

Links The Future, Writ Small lifesciences.umich.edu/research/featured/

Michigan Nanotechnology Institute for Medicine and Biological Sciences nano.med.umich.edu/

News Media Contacts:
James R. Baker MDRuth Dow Doan Professor of Biologic Nanotechnology, Professor of Internal MedicineDirector, Michigan Nanotechnology Institute for Medicine and Biological SciencesContact: Sally Pobojewski, pobo@umich.edu, (734) 764-2220

David Kohn Ph.D.Professor, Biologic and Materials Sciences and Biomedical Engineering(734) 764-2206 dhkohn@umich.edu

Martin Philbert, Ph.D.Professor of ToxicologySenior Associate Dean For Research, School of Public Health(734) 763-4523 philbert@umich.edu

Shuichi Takayama Ph.D.Assistant Professor of Biomedical Engineering and Macromolecular Science and Engineering(734) 615-5539http://www.eurekalert.org/pub_releases/2006-02/takayama@umich.edu

Contact: Karl Leif Bates batesk@umich.edu 734- 647-1842 University of Michigan

more at Nano or Chemistry and nanoparticles or atomic level materials and biologically or Nanotechnology and Nanotech or Science and engineering or molecular and medical imaging or nanoscale and Bioengineering or biomedical

Related: Keyword Nanotech Sunday, February 19, 2006 nano-canary in the nanotoxicology coalmine, Sunday, December 04, 2005 Nano-cages 'fill up' with hydrogen, Sunday, November 13, 2005 Testing toxicity of nanomaterials, Sunday, October 23, 2005 single-molecule car, 'Nanocar', Sunday, August 28, 2005 Writing at the nanoscale, Thursday, May 26, 2005 discontinuous palladium, siloxane self-assembled monolayer, Sunday, May 08, 2005 Center for Nanoscale Materials, Monday, April 25, 2005 Nanomagnets, Nanocomposite, Monday, March 21, 2005 porphyrin tubes may lead to new nanodevices, inexpensive hydrogen fuel